@article{oai:repo.qst.go.jp:00080167,
 author = {Fujiwara, Kentaro and Akiba, Hiroki and B Tsuji, Atsushi and Sudo, Hitomi and Sugyo, Aya and Nagatsu, Kotaro and Ming-Rong, Zhang and Iwanari, Hiroko and Osamu, Kusano-Arai and Kudo, Shota and Kikuchi, Chika and Tsumoto, Kouhei and Momose, Toshimitsu and Hamakubo, Takao and Higashi, Tatsuya and Fujiwara, Kentaro and Tsuji, Atsushi and Sudo, Hitomi and Sugyo, Aya and Nagatsu, Kotaro and Ming-Rong, Zhang and Higashi, Tatsuya},
 issue = {7},
 journal = {Nuclear medicine communications},
 month = {Jul},
 note = {We previously reported In-labeled anti-cadherin17 (CDH17) IgG visualized CDH17-positive gastric cancer xenografts. Unfortunately, a long waiting time was required to obtain high-contrast images due to long blood retention (blood half-life: 26 h). To accelerate blood clearance, we have developed anti-CDH17 minibody (D2101 minibody) and evaluated the pharmacokinetics in gastric cancer mouse models.},
 pages = {688--695},
 title = {64Cu-labeled minibody D2101 visualizes CDH17-positive gastric cancer xenografts with short waiting time.},
 volume = {41},
 year = {2020}
}